REVIEW OF AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CLINICAL GUIDELINES FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS

Abstract

Glucocorticoids (GCs) play an important role in treating many inflammatory diseases due to their anti-inflammatory and immunomodulatory activities and are used in many fields of medicine. Despite their clinical benefits of GCs used to treat patients with chronic inflammatory diseases, prolonged administration of these medications, especially oral ones, frequently causes serious complications, such as bone loss and fractures. The present paper reviews the latest American College of Rheumatology clinical guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis, which were published in 2017. It provides comments, by taking into account the Russian guidelines on the diagnosis, prevention, and treatment of glucocorticoid-induced osteoporosis.

Keywords

• clinical guidelines
• osteoporosis
• glucocorticoids
• glucocorticoid-induced osteoporosis
• fracture risk
• treatment of glucocorticoid-induced osteoporosis